Last update 23 Jan 2025

CEA x CD 66 antigen

Basic Info

Related Targets
CEACD 66 antigen

Related

1
Drugs associated with CEA x CD 66 antigen
CEA-targeted vaccine(Etubics Corp.)
Target
CD 66 antigen x CEA
Mechanism
CD 66 antigen modulators [+1]
Active Org.
Etubics Corp.Etubics Corp.
Originator Org.
Etubics Corp.Etubics Corp.
Active Indication
Neoplasms
Inactive Indication
Breast Cancer [+14]
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
19
Clinical Trials associated with CEA x CD 66 antigen
NCT03563157
/ TerminatedPhase 1/2
NANT Colorectal Cancer (CRC) Vaccine: A Phase 1b/2 Trial of the NANT CRC Vaccine vs Regorafenib in Subjects With Metastatic CRC Who Have Been Previously Treated With Standard-of-Care Therapy
100 Clinical Results associated with CEA x CD 66 antigen
Login to view more data
100 Translational Medicine associated with CEA x CD 66 antigen
Login to view more data
0 Patents (Medical) associated with CEA x CD 66 antigen
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free